NeuroBo Pharmaceuticals Net Income 1970-1969 | MTVA
NeuroBo Pharmaceuticals net income from 1970 to 1969. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
NeuroBo Pharmaceuticals Annual Net Income
(Millions of US $) |
NeuroBo Pharmaceuticals Quarterly Net Income
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
